2666 — Genertec Universal Medical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapTurnaround

Annual income statement for Genertec Universal Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,521	9,914	12,073	13,650	13,663
Cost of Revenue
Gross Profit	3,554	4,199	4,494	4,572	4,592
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,137	7,207	9,348	10,751	10,732
Operating Profit	2,384	2,707	2,725	2,899	2,931
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	2,365	2,692	2,703	2,866	2,907
Provision for Income Taxes
Net Income After Taxes	1,814	2,030	2,086	2,199	2,258
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,747	1,948	1,960	2,110	2,104
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,648	1,835	1,926	2,062	2,047
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.07	1.02	0.929	0.99	1.01
Dividends per Share